Loading investment round...
Loading investment round...
Round announcement
businesswire.com
Airnexis Takes Flight 200m Links Chinese Pharma Copd Asset 955m Biobucks Deal
fiercebiotech.com
Airnexis Therapeutics
thepharmaletter.com
Airnexis Therapeutics
notice.co
Portfolio
orbiimed.com
Portfolio
srone.com
News
enavatesciences.com
Airnexis Therapeutics Launches With 200m Series A To Advance Phase 2 Dual Pde3 4 Inhibitor An01 For Chronic Obstructive Pulmonary Disease Copd
biospace.com
Maria Fardis Airnexis Therapeutics Launches With 200m Series A To Advance Copd Drug Innovation
oncodaily.com
Haisco Grants Global Rights Of Innovative Drug Hsk39004 To Airnexis In Deal Exceeding Usd 1 Billion 302031798.Html
prnewswire.com
Haisco Pharmaceutical Signs Exclusive Licensing Agreement With U S Based Airnexis With Total Deal Value Reaching 1 063 Billion
vcbeat.net
Mixed
A mixed round, some signals are off the norm.
Round size vs peers
Far above the typical Series A round (16.7× the median), an outlier.
Syndicate size
Healthy syndicate of 5 investors.
Insider conviction
All-new money, no prior investors re-upped.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
